{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:05:49Z","timestamp":1793379949563,"version":"4.5.0"},"reference-count":142,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001592","name":"Higher Education Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["enviromicro-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Microbial Biotechnology"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    mRNA vaccines have emerged as promising alternatives to conventional vaccines because of their flexible design, high immunogenicity, favourable safety profile, efficacy and potential for rapid clinical development. The accelerated development of mRNA vaccines during the COVID\u201019 pandemic has revolutionised the field of vaccinology, highlighting their potential for combating emerging infectious diseases. The mRNA platforms can induce robust humoral as well as CD4+ and CD8+ T\u2010cell\u2010mediated immunity, offering broader protection than subunit protein vaccines. Consequently, they have been extensively studied against a wide range of viral, bacterial and parasitic infections, although the development of mRNA vaccines against bacterial and parasitic infections has lagged behind those targeting viruses. This review highlights recent studies on mRNA vaccine development and applications against a wide range of infectious diseases including non\u2010COVID viral infections, bacterial pathogens such as Mycobacteria or\n                    <jats:styled-content style=\"fixed-case\">\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    <\/jats:styled-content>\n                    and parasitic infections, including malaria. Moreover, it discusses key optimisation strategies and highlights candidates that have progressed to clinical trials, and the current challenges in enhancing immunogenicity and improving delivery systems.\n                  <\/jats:p>","DOI":"10.1111\/1751-7915.70212","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T14:34:15Z","timestamp":1756132455000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Harnessing the Potential of\n                    <scp>mRNA<\/scp>\n                    Vaccines Against Infectious Diseases"],"prefix":"10.1111","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-4678","authenticated-orcid":false,"given":"Nouran","family":"Rezk","sequence":"first","affiliation":[{"name":"School of Biomolecular and Biomedical Science University College Dublin  Dublin Ireland"},{"name":"UCD Conway Institute of Biomolecular and Biomedical Research University College Dublin  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6389-2542","authenticated-orcid":false,"given":"Siobh\u00e1n","family":"McClean","sequence":"additional","affiliation":[{"name":"School of Biomolecular and Biomedical Science University College Dublin  Dublin Ireland"},{"name":"UCD Conway Institute of Biomolecular and Biomedical Research University College Dublin  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00041-24"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071972"},{"key":"e_1_2_16_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn4955"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065687"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.12.070"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.06.008"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae329"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01568-21"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm0271"},{"key":"e_1_2_16_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw7083"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152310"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.035"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1099991"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab269"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00763-2"},{"key":"e_1_2_16_17_1","unstructured":"BioNTech SE.2024.\u201cAn Exploratory Phase I Randomized Observer\u2010Blind Placebo\u2010Controlled Dose Escalation Trial Evaluating the Safety Tolerability and Immunogenicity of an Investigational RNA\u2010based Vaccine for Active Immunization Against Malaria clinicaltrials.gov.\u201d"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00520-23"},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-020-00204-y"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00656-4"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13040383"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00893-1"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2022.09.013"},{"key":"e_1_2_16_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040621"},{"key":"e_1_2_16_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00283-5"},{"key":"e_1_2_16_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121382"},{"key":"e_1_2_16_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00420-6"},{"key":"e_1_2_16_28_1","unstructured":"Clinicaltrials.gov.2021.\u201cA Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD\u2010GT8 60mer mRNA Vaccine (mRNA\u20101644) and Core\u2010g28v2 60mer mRNA Vaccine (mRNA\u20101644v2\u2010Core) (ClinicalTrials.gov Identifier: NCT05001373).\u201dUS Natl Libr Med."},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf3309"},{"key":"e_1_2_16_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-021-00176-7"},{"key":"e_1_2_16_31_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.129"},{"key":"e_1_2_16_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8010090"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15071483"},{"key":"e_1_2_16_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008795"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00764-2"},{"key":"e_1_2_16_36_1","volume-title":"mResvia","author":"European Medicines Agency","year":"2024"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207566"},{"key":"e_1_2_16_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7030115"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.074"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.06.003"},{"key":"e_1_2_16_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.04.018"},{"key":"e_1_2_16_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01562-6"},{"key":"e_1_2_16_43_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7027e2"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2022.01.032"},{"key":"e_1_2_16_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9090959"},{"key":"e_1_2_16_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032700"},{"key":"e_1_2_16_47_1","unstructured":"Gouma S. C.Furey J. J. S.Santos K.Parkhouse M.Weirick andH.Muramatsu.2022.\u201cNucleoside\u2010Modified mRNA\u2010Based Influenza Vaccines Adaptation.\u201d"},{"key":"e_1_2_16_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.10.027"},{"key":"e_1_2_16_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00577-8"},{"key":"e_1_2_16_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2022.07.003"},{"key":"e_1_2_16_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39421-5"},{"key":"e_1_2_16_52_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042420-112725"},{"key":"e_1_2_16_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.10.019"},{"key":"e_1_2_16_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41628-5"},{"key":"e_1_2_16_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41578-021-00358-0"},{"key":"e_1_2_16_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00493-6"},{"key":"e_1_2_16_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00775-24"},{"key":"e_1_2_16_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108015"},{"key":"e_1_2_16_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00752-5"},{"key":"e_1_2_16_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2484088"},{"key":"e_1_2_16_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.06.008"},{"key":"e_1_2_16_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200"},{"key":"e_1_2_16_63_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313139"},{"key":"e_1_2_16_64_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101088"},{"key":"e_1_2_16_65_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1036"},{"key":"e_1_2_16_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.10.011"},{"key":"e_1_2_16_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00786-9"},{"key":"e_1_2_16_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010130"},{"key":"e_1_2_16_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad693"},{"key":"e_1_2_16_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39376-7"},{"key":"e_1_2_16_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126518"},{"key":"e_1_2_16_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104188"},{"key":"e_1_2_16_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01919-7"},{"key":"e_1_2_16_74_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1288879"},{"key":"e_1_2_16_75_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1068162023020152"},{"key":"e_1_2_16_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2389115"},{"key":"e_1_2_16_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1490044"},{"key":"e_1_2_16_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060570"},{"key":"e_1_2_16_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84823-0"},{"key":"e_1_2_16_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020268"},{"key":"e_1_2_16_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00345-0"},{"key":"e_1_2_16_82_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.3c18830"},{"key":"e_1_2_16_83_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1172691"},{"key":"e_1_2_16_84_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206333119"},{"key":"e_1_2_16_85_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121464"},{"key":"e_1_2_16_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00629-7"},{"key":"e_1_2_16_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00506-3"},{"key":"e_1_2_16_88_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.210.Supp.141.03"},{"key":"e_1_2_16_89_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00486"},{"key":"e_1_2_16_90_1","unstructured":"ModernaTX Inc.2024.\u201cA Phase 2 Randomized Observer\u2010Blind Placebo\u2010Controlled Dose Confirmation Study to Evaluate the Safety Tolerability and Immunogenicity of Zika Vaccine mRNA\u20101893 in Adults Aged 18 Through 65\u2009Years and Living in Endemic and Non\u2010Endemic Flavivirus Areas.\u201dclinicaltrials.gov."},{"key":"e_1_2_16_91_1","first-page":"32","article-title":"Efficient Induction of T Cells Against Conserved HIV\u20101 Regions by Mosaic Vaccines Delivered as Self\u2010Amplifying mRNA","volume":"12","author":"Moyo N.","year":"2019","journal-title":"Molecular Therapy"},{"key":"e_1_2_16_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06800-3"},{"key":"e_1_2_16_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01093-1"},{"key":"e_1_2_16_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.02.001"},{"key":"e_1_2_16_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_2_16_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00650-3"},{"key":"e_1_2_16_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32149-8"},{"key":"e_1_2_16_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243"},{"key":"e_1_2_16_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00635-9"},{"key":"e_1_2_16_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2023.100066"},{"key":"e_1_2_16_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102302"},{"key":"e_1_2_16_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00311-w"},{"key":"e_1_2_16_103_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020888"},{"key":"e_1_2_16_104_1","doi-asserted-by":"publisher","DOI":"10.1086\/533452"},{"key":"e_1_2_16_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.017"},{"key":"e_1_2_16_106_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01424"},{"key":"e_1_2_16_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122617"},{"key":"e_1_2_16_108_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj9827"},{"key":"e_1_2_16_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01432-5"},{"key":"e_1_2_16_110_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1247041"},{"key":"e_1_2_16_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.04.064"},{"key":"e_1_2_16_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126847"},{"key":"e_1_2_16_113_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-080219-023629"},{"key":"e_1_2_16_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58328-x"},{"key":"e_1_2_16_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.103"},{"key":"e_1_2_16_116_1","volume-title":"MRESVIA","author":"U.S. Food and Drug Administration","year":"2025"},{"key":"e_1_2_16_117_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.945706"},{"key":"e_1_2_16_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00042-2"},{"key":"e_1_2_16_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2019.100766"},{"key":"e_1_2_16_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00549-y"},{"key":"e_1_2_16_121_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12020102"},{"key":"e_1_2_16_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00672-4"},{"key":"e_1_2_16_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00320-6"},{"key":"e_1_2_16_124_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1524317"},{"key":"e_1_2_16_125_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307079"},{"key":"e_1_2_16_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00890-4"},{"key":"e_1_2_16_127_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02482-20"},{"key":"e_1_2_16_128_1","volume-title":"Potential Benefits and Limitations of MRNA Technology for Vaccine Research and Development for Infectious Diseases and Virus\u2010Induced Cancers: Report of the WHO Science Council","author":"World Health Organization","year":"2023"},{"key":"e_1_2_16_129_1","volume-title":"WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance","author":"World Health Organization","year":"2024"},{"key":"e_1_2_16_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00306-8"},{"key":"e_1_2_16_131_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10691-7"},{"key":"e_1_2_16_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106425"},{"key":"e_1_2_16_133_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156588"},{"key":"e_1_2_16_134_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2204151"},{"key":"e_1_2_16_135_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01579-1"},{"key":"e_1_2_16_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.07.013"},{"key":"e_1_2_16_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01574-5"},{"key":"e_1_2_16_138_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2192815"},{"key":"e_1_2_16_139_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7030096"},{"key":"e_1_2_16_140_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11081304"},{"key":"e_1_2_16_141_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836274"},{"key":"e_1_2_16_142_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8010123"},{"key":"e_1_2_16_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.01.017"}],"container-title":["Microbial Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/sfamjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1751-7915.70212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:53:59Z","timestamp":1762275239000},"score":1,"resource":{"primary":{"URL":"https:\/\/sfamjournals.onlinelibrary.wiley.com\/doi\/10.1111\/1751-7915.70212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":142,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1111\/1751-7915.70212"],"URL":"https:\/\/doi.org\/10.1111\/1751-7915.70212","archive":["Portico"],"relation":{},"ISSN":["1751-7915","1751-7915"],"issn-type":[{"value":"1751-7915","type":"print"},{"value":"1751-7915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"2025-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70212"}}